Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce drugs, including a new version of Keytruda, creating 4,500 jobs by 2030, aligning with US d...
Merck & Co. Inc. is investing $1 billion in a new Delaware facility to produce drugs and a new version of Keytruda, creating 4,500 jobs by 2030. This move aligns with a broader tre...
Merck & Co. Inc. announces a $1 billion investment in a new Delaware facility to produce innovative drugs and a new Keytruda formulation, creating 4,500 jobs by 2030, aligning with...
Regeneron Pharmaceuticals Inc. partners with Fujifilm Diosynth Biotechnologies in a $3 billion deal to enhance US production of biologic medicines, with total investments in produc...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have entered a $3 billion agreement to produce biologic medicines in North Carolina, marking a significant step...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have announced a $3 billion partnership to enhance the production of biologic medicines in the US, with additio...
Roche plans a $50 billion investment in the US to expand pharmaceutical manufacturing and create over 12,000 jobs, reinforcing its commitment to innovation and development in the c...
Roche announces a $50 billion investment in the US to expand pharmaceutical operations, creating over 12,000 jobs and strengthening its global presence in healthcare innovation.
AstraZeneca has scrapped plans for a vaccine plant near Liverpool after failing to agree on government funding. The move highlights challenges in UK's vaccine production ambitions,...
